Alan M. Zaslavsky, PhD

home / authors / alan-m-zaslavsky-phd

Articles

October 4th 2022

Turnover Among New Medicare Advantage Enrollees May Be Greater Than Perceived

Jeffrey Dong, MD Alan M. Zaslavsky, PhD John Z. Ayanian, MD, MPP Bruce E. Landon, MD, MBA

Enrollees who join Medicare Advantage undergo significant turnover in the years following enrollment.

March 2nd 2021

Use of Diabetes Medications in Traditional Medicare and Medicare Advantage

Bruce E. Landon, MD, MBA Alan M. Zaslavsky, PhD Jeffrey Souza, BA John Z. Ayanian, MD, MPP

Medicare Advantage enrollees are more likely to be treated with metformin and sulfonylureas and less likely to receive costly newer medications than those in traditional Medicare.

August 18th 2015

A Comparison of Relative Resource Use and Quality in Medicare Advantage Health Plans Versus Traditional Medicare

Bruce E. Landon, MD, MBA, MSc Alan M. Zaslavsky, PhD Robert Saunders, PhD L. Gregory Pawlson, MD, MPH Joseph P. Newhouse, PhD John Z. Ayanian, MD, MPP

Compared with traditional Medicare, relative resource use for those with diabetes or cardiovascular disease is lower in Medicare Advantage, while quality of care is higher.